← Back to headlines
MacroGenics to sell manufacturing operations to Bora for $122.5M
MacroGenics announced its decision to sell its manufacturing operations to Bora Pharmaceuticals for $122.5 million. This transaction marks a significant strategic move for the biopharmaceutical company.
11 May, 22:02 — 11 May, 22:02
Sources
Showing 1 of 1 sources
